Clinical Trial

The Better, Harder, Faster, Stronger Study

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate changes in the electronic Frailty Index (eFI) score following 3-4 cycles of neoadjuvant chemotherapy (NACT) in participants with advanced ovarian and endometrial cancer.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-10-22; most recent amendment 2026-07-14.
Trial Details
NCT Number NCT07220512
Lead Sponsor Wake Forest University Health Sciences
Collaborators: Atrium Health Wake Forest Baptist
Conditions Frailty at Older Adults, Ovarian Cancer, Endometrial Cancer, Cognitive Dysfunction, Neoadjuvant Chemotherapy
Enrollment 35 participants
Start Date 2025-07-28
Primary Completion 2026-11 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-15